Group One Trading’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-93
Closed -$1.33K 8132
2022
Q4
$1.33K Hold
93
﹤0.01% 6767
2022
Q3
$2K Buy
+93
New +$2.4K ﹤0.01% 7228
2022
Q1
Sell
-283
Closed -$13K 8914
2021
Q4
$13K Sell
283
-152
-35% -$9.11K ﹤0.01% 7245
2021
Q3
$31K Buy
+435
New +$49.5K ﹤0.01% 6905

Other funds holding ASLN

Group One Trading's ASLN Position: Q3 2023 in Review

Group One Trading sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2023, closing a stake of 51 shares — an estimated $1.5K sold.

Group One Trading first reported a position in ASLN in Q3 2021 and held it in 8 quarters. The position peaked at $30K in Q3 2021. 19 funds tracked by Wall St. Rank hold ASLN as of Q3 2023.

  • Group One Trading reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 51 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2023, an estimated $1.5K.
  • Group One Trading first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2021 and held it in 8 quarters.
  • Group One Trading's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $30K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.